4th Quarter - Termination

TIBER CREEK GROUP for SMITHS GROUP PLC

Firm
Client
Income
$30,000
Expenses
—
Terminated
Dec 31, 2022

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Medicare reimbursement for opioid alternative treatments, including H.R. 3259 & S. 586 - NOPAIN Act. The Consolidated Appropriations Act, 2023, Sec. 4135 (PL 117-328).

LobbyistCovered position, as disclosed
JAMES HEIMBACH —
EMILY KIRLIN —
COREY MALMGREN —
ANDREW MCKECHNIE —
JOHN KIRKLAND TWOMEY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: S. 586 (117th), H.R. 3259 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.